Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Obstructive Lung Diseases

  Free Subscription


2 Allergy
1 Am J Respir Cell Mol Biol
3 Am J Respir Crit Care Med
1 Ann Allergy Asthma Immunol
2 Arerugi
1 BMC Pediatr
3 Chest
1 Clin Exp Allergy
1 Eur Respir J
3 J Allergy Clin Immunol
2 J Asthma
2 J Investig Allergol Clin Immunol
2 Pediatr Pulmonol
2 PLoS One
1 Pneumologie
2 Respir Med
4 Respir Res
1 Rev Mal Respir

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. LAMMERS A, Brinkman P, Te Nijenhuis L, de Vries R, et al
    Increased day-to-day fluctuations in exhaled breath profiles aftera rhinovirus challenge in asthma.
    Allergy. 2021 Mar 11. doi: 10.1111/all.14811.
    PubMed         Abstract available

  2. GAJEWSKI A, Gawrysiak M, Szewczyk R, Gulbas I, et al
    IL-33 augments the effect of rhinovirus HRV16 on inflammatory activity of human lung vascular endothelium - possible implications for rhinoviral asthma exacerbations.
    Allergy. 2021 Mar 8. doi: 10.1111/all.14806.

    Am J Respir Cell Mol Biol

    Seeing is Believing: Extravascular Platelet Recruitment in Asthma and Allergic Inflammation.
    Am J Respir Cell Mol Biol. 2021 Mar 11. doi: 10.1165/rcmb.2021-0045.

    Am J Respir Crit Care Med

  4. PUEBLA NEIRA DA, Hsu ES, Kuo YF, Ottenbacher KJ, et al
    Readmissions Reduction Program: Mortality and Readmissions for Chronic Obstructive Pulmonary Disease.
    Am J Respir Crit Care Med. 2021;203:437-446.
    PubMed         Abstract available

  5. HAN MK, Agusti A, Celli BR, Criner GJ, et al
    From GOLD 0 to Pre-COPD.
    Am J Respir Crit Care Med. 2021;203:414-423.

  6. HUDALI TH, Bodduluri S, Dransfield MT, Bhatt SP, et al
    Association between Inhaled Corticosteroids and Expiratory Central Airway Collapse in Smokers.
    Am J Respir Crit Care Med. 2021;203:518-521.

    Ann Allergy Asthma Immunol

  7. TSUZUKI R, To M, Yamawaki S, Kono Y, et al
    Inhibitory effect of calcium channel blockers on the deterioration of lung function in adult-onset asthma.
    Ann Allergy Asthma Immunol. 2021 Mar 8. pii: S1081-1206(21)00175.


    Arerugi. 2021;70:95-99.

    Arerugi. 2021;70:107-111.

    BMC Pediatr

  10. ZHANG FZ, Qin L, Yuan JX, Tang LF, et al
    Plastic bronchitis due to adenoviral infection: a case report.
    BMC Pediatr. 2020;20:61.
    PubMed         Abstract available


  11. SEHGAL IS, Dhooria S, Bal A, Aggarwal AN, et al
    A Young Girl With Bronchiectasis and Elevated Sweat Chloride.
    Chest. 2021;159:e155-e158.
    PubMed         Abstract available

  12. VALENTIN V, Bervar JF, Vincent-Delorme C, Smol T, et al
    Filamin A Mutations: A New Cause of Unexplained Emphysema in Adults?
    Chest. 2021;159:e131-e135.
    PubMed         Abstract available

  13. SULAIMAN I, Costello RW
    Adherence to Asthma Treatments: An Audit of a Warehouse of Data.
    Chest. 2021;159:891-892.

    Clin Exp Allergy

  14. REJNO GR, Lundholm CL, Saltvedt SS, Larsson KL, et al
    Maternal asthma and early foetal growth, the MAESTRO study.
    Clin Exp Allergy. 2021 Mar 11. doi: 10.1111/cea.13864.
    PubMed         Abstract available

    Eur Respir J

  15. PRICE OJ, Kucera KL, Price HM, Drezner JA, et al
    Asthma-related sudden death in athletes: A retrospective analysis of the U.S. NCCSIR database (1982-2018).
    Eur Respir J. 2021 Mar 7. pii: 13993003.00088-2021.

    J Allergy Clin Immunol

  16. JACKSON DJ, Busse WW, Togias A, Gern JE, et al
    J Allergy Clin Immunol. 2020;146:1214-1215.

  17. TANG HHF, Teo SM, Sly PD, Holt PG, et al
    The intersect of genetics, environment, and microbiota in asthma-perspectives and challenges.
    J Allergy Clin Immunol. 2021;147:781-793.
    PubMed         Abstract available

  18. ZHANG Y, Wei J, Shi Y, Quan C, et al
    Early-life exposure to submicron particulate air pollution in relation to asthma development in Chinese preschool children.
    J Allergy Clin Immunol. 2021 Mar 5. pii: S0091-6749(21)00359.
    PubMed         Abstract available

    J Asthma

  19. BUSSE WW, Fang J, Marvel J, Tian H, et al
    Uncontrolled asthma across GINA treatment steps 2 - 5 in a large US patient cohort.
    J Asthma. 2021 Mar 12:1-15. doi: 10.1080/02770903.2021.1897834.
    PubMed         Abstract available

  20. VENKITAKRISHNAN R, Thomas PK, Bansal A, Ghosh I, et al
    Fluticasone/Formoterol compared withother ICS/LABAs in asthma: A systematic review.
    J Asthma. 2021 Mar 8:1-13. doi: 10.1080/02770903.2021.1900864.
    PubMed         Abstract available

    J Investig Allergol Clin Immunol

  21. OLAGUIBEL A, Oleaga M, Iraola A, Cortaberria R, et al
    Exhaled Nitric Oxide (eNO) Measurements With the New evernoa Device Are Valid and Reproducible Through an Extended Range of eNO Levels.
    J Investig Allergol Clin Immunol. 2020;30:147-149.

  22. SHIMIZU Y, Kurosawa M, Sutoh Y, Sutoh E, et al
    Long-Term Treatment With Anti-Interleukin 5 Antibodies in a Patient with Chronic Eosinophilic Pneumonia.
    J Investig Allergol Clin Immunol. 2020;30:154-155.

    Pediatr Pulmonol

  23. RODRIGUEZ-MARTINEZ CE, Sossa-Briceno MP, Sinha IP
    When adherence and inhalation technique matter: Difficult-to-control pediatric asthma in low- to middle-income countries.
    Pediatr Pulmonol. 2021 Mar 8. doi: 10.1002/ppul.25342.
    PubMed         Abstract available

  24. FAN HF, He CH, Yin GQ, Qin Y, et al
    Frequency of asthma exacerbation in children during the coronavirus disease pandemic with strict mitigative countermeasures.
    Pediatr Pulmonol. 2021 Mar 8. doi: 10.1002/ppul.25335.
    PubMed         Abstract available

    PLoS One

  25. COSTA PPC, Waller SB, Dos Santos GR, Gondim FL, et al
    Anti-asthmatic effect of nitric oxide metallo-donor FOR811A [cis-[Ru(bpy)2(2-MIM)(NO)](PF6)3] in the respiratory mechanics of Swiss mice.
    PLoS One. 2021;16:e0248394.
    PubMed         Abstract available

  26. YAMADA H, Nakajima M, Matsuyama M, Morishima Y, et al
    Identification of distinct phenotypes related to benralizumab responsiveness in patients with severe eosinophilic asthma.
    PLoS One. 2021;16:e0248305.
    PubMed         Abstract available


  27. IDZKO M, Buhl R, Eber E, Hamelmann E, et al
    [COVID-19 Vaccination in Asthma Patients Treated with Biologicals - Statement of the Austrian Society of Pneumology and German Respiratory Society].
    Pneumologie. 2021 Mar 12. doi: 10.1055/a-1373-9381.
    PubMed         Abstract available

    Respir Med

  28. MENDY A, Wu X, Keller JL, Fassler CS, et al
    Long-term exposure to fine particulate matter and hospitalization in COVID-19 patients.
    Respir Med. 2021;178:106313.
    PubMed         Abstract available

  29. SCOSYREV E, van Zyl-Smit R, Kerstjens H, Gessner C, et al
    Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trials.
    Respir Med. 2021;180:106311.
    PubMed         Abstract available

    Respir Res

  30. GREULICH T, Tuffers J, Mager S, Eder A, et al
    High eosinophil blood counts are associated with a shorter length of hospital stay in exacerbated COPD patients - a retrospective analysis.
    Respir Res. 2020;21:106.
    PubMed         Abstract available

  31. WILSON AC, Kumar PL, Lee S, Parker MM, et al
    Heme metabolism genes Downregulated in COPD Cachexia.
    Respir Res. 2020;21:100.
    PubMed         Abstract available

  32. MACKAY AJ, Kostikas K, Roche N, Frent SM, et al
    Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study.
    Respir Res. 2020;21:93.
    PubMed         Abstract available

  33. SCHERR A, Schumann DM, Karakioulaki M, Franchetti L, et al
    Endothelial dysfunction is not a predictor of outcome in chronic obstructive pulmonary disease.
    Respir Res. 2020;21:90.
    PubMed         Abstract available

    Rev Mal Respir

    [Diet and asthma: Better eating for better breathing?]
    Rev Mal Respir. 2021 Mar 3. pii: S0761-8425(21)00129.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.